Maple Grove, MN – August 5, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of TORPENZ™ (everolimus) Tablets in 2.5 mg, 5 mg, 7.5 mg and 10 mg strengths. TORPENZ™ is an ... Read More
Maple Grove, MN – July 1, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today unveiled its enhanced Promise of Support™ Program – a patient-centered program designed to offer patients, caregivers, and healthcare providers in the rare ... Read More
Company Recognized in Alliance Program Excellence Category
Maple Grove, MN – June 25, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has been named by The Association of Strategic Alliance Professionals (ASAP) as ... Read More
Company Named Best Overall Branded Pharmaceutical Product Manufacturer in its Sales Category for Fourth Consecutive Year
Maple Grove, MN – June 19, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has been awarded ... Read More
Maple Grove, MN – May 30, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has been honored with a Governor’s Workplace Safety Award which recognizes excellence in occupational injury prevention. The award was ... Read More
Collaboration Supported by DEED Grant Supports Customized Workforce Training Program
Maple Grove, MN – May 22, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced a significant collaboration with Hennepin Technical College aimed at advancing workforce ... Read More
Company Recognized in Individual Long-Standing Alliance and Individual Company Alliance Excellence Award Categories
Maple Grove, MN – May 14, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has been named by The Association of ... Read More
Discover the Company’s Promise of Support™ Program at Booth #818
Maple Grove, MN – April 12, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be participating in the 2024 American Academy of ... Read More
Acquisition expands Bora’s North American footprint with first US manufacturing site Taipei, Taiwan, April 1st, 2024 – Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that it has successfully completed the ... Read More
Maple Grove, MN – March 29, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately ... Read More
